Skip to content
Home/Companies/Biotech/Alloy Therapeutics
Alloy Therapeutics

Alloy Therapeutics

Biotech·US·Active
Entry
–
Hold
–
Status
Active

Who owns Alloy Therapeutics?

Alloy Therapeutics is currently owned by Mubadala Capital.

Hand-verified · updated 2026-04-21

Mubadala Capital
Investor
Mubadala Capital
Fund attribution unclassified.

Key facts

HQUSA
SectorBiotech
Websitealloytx.com

More from Mubadala Capital Other Investments

Other portfolio companies in the same fund.

Airtime
Airtime
Active
TMTUS
Alliance Laundry System
Alliance Laundry System
Active
IndustrialsUS
Arbol
Arbol
Active
InsurTechUS
Athletico Physical Therapy
Athletico Physical Therapy
Active
HealthcareUS
Babel Group
Babel Group
Active
TMTUK
Balbix
Active
CybersecurityUS

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Alloy Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Alloy Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Alloy Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue